Professional Documents
Culture Documents
The FDA Data Standards Catalog (Catalog) lists the data standards and terminologies that FDA supports for use in regulatory
submissions to better enable the evaluation of safety, effectiveness, and quality of FDA-regulated products. In addition, the FDA
has the statutory and regulatory authority to require certain standards and terminologies and these are identified in the Catalog
with the date the requirement begins and, as needed, the date the requirement ends, and information sources. The submission
of data using standards or terminologies not listed in the Catalog should be discussed with the Agency in advance. Where the
Catalog expresses support for more than one standard or terminology for a specific use, the sponsor or applicant may select one
to use or can discuss, as appropriate, with their review division.
Sponsors and applicants should review the Catalog terms below, as well as any references associated with specific standards or
terminologies.
Standards Development Organization The organization developed and maintains the standard or terminology
For the purposes of this catalog, “supported” means the receiving FDA Center has
Supported Version established processes and technology to support receiving, processing, reviewing,
and archiving files in the specified standard.
This lists the version of the implementation guide that is supported by FDA. The
Implementation Guide Version
implementation guide provides additional instruction for the standard.
This identifies which centers (e.g., CBER, CDER, CDRH, CSFAN, CVM, CTP,OC,
FDA Center
ORA, NCTR) in FDA use the supported standard.
This is the date when sponsors can start using the standard or terminology.
Date Support Begins "Ongoing" means that FDA supports the listed standard for electronic submissions
as of the initial Catalog release date, 6/13/2011.
If a study started before the support ends date, a study can continue to use this
specified standard. If a study starts after the support ends date, a study can
NO longer use the specified standard. Sponsors cannot use the standard or
Date Support Ends
terminology after this date. Generally, a waiver process may be available.
Sponsors and applicants should consult with their review division. An empty field
in this column means that a support end date has not been established.
This is the date when the requirement to use a specific version of a standard or
terminology begins for any study that starts after the 'Requrement Begins' date'.
Date Requirement Begins After this date, sponsors and applicants must use the indicated standard or
terminology in submissions as per statute or regulation. An empty field in this
column means that a requirement date has not been established.
If a study started on the requirement ends date, a study can continue to use this
specified standard. If a study starts after the requirement ends date, a study
can NO longer use the specified standard.The standard or terminology can no
Date Requirement Ends longer be used to submit data for studies starting after this date. Generally, a
waiver process may be available. Sponsors and applicants should consult with
their review division. An empty field in this columns means that a support end date
has not been established.
Reference documents or webpage that provides information on the FDA's
Statutory and Regulaory Authority
authority to request the submission of data in specified formats.
Additional information to assist sponsors and applicants in using the listed data
Information Sources
standards and terminologies
FDA Data Standards Catalog v7.3 (09-14-2021) - Supported and Required Standards
For full description of column headings, see Instr.& Column Descriptions tab
Date Support Date Requirement
Standards Supported Date Support Date Requirement
Data Exchange Exchange Begins Begins Statutory, Regulatory, or Guidance
Use Development Supported Version Implementation FDA Center(s) Ends Ends Information Sources
Standard Format (MM/DD/YYYY) (MM/DD/YYYY) Authority
Organization (SDO) Guide Version (MM/DD/YYYY) (MM/DD/YYYY)
[10] [11]
Product Labeling
Providing Regulatory Submissions in Electronic
Structured
Format - Drug
Product
Establishment
Labeling (SPL)
Registration
Implementation
and Drug
Guide
Listing
with Validation Procedures
Submissions
Structured Product 04/01/2005 [3]
Labeling (SPL) XML Health Level 7 (HL7) Release 5 CDER, CBER Ongoing 12/11/2003 [4]
Structured Product
Labeling (SPL)
Postmarketing
Implementation Guide
Safety Reporting-
with Validation Electronic Submission of Lot Distribution Reports FDA Structured Product Labeling Resources
Lot Distribution
Procedures Version 1
Reports
Revision
201412101457
SPL XML HL7 Release 5 CBER 06/10/2015 n/a 06/10/2015 n/a
Postmarketing
Safety Reporting -
Postmarketing Safety Reports: Electronic Submission
HL7
Requirements
ICSR Files: Complete Packet eMDR
Adverse Events for
Medical Devices Individual Case
Safety Report
(ICSR) XML HL7 Release 1 N/A CDRH Ongoing
Postmarketing
Safety Reporting-
Adverse Events for Guidance for Submission of Veterinary AER Adverse Drug Experience (ADE) Reports
Veterinary Adverse Event Reporting for Manufacturers
Animal Drugs
(ICSR)
ICSR XML ISO/HL7 Release 2 N/A CVM Ongoing
Postmarketing
Safety Reporting -
Adverse Events for Postmarketing Safety Reports: Electronic Submission
FDA Adverse
Requirements
Events Reporting System (FAERS) Electronic Submissions
Drugs and
Biologics (ICSR)
ICSR XML ICH E2B Release 2 ICH E2B CDER, CBER Ongoing
Documents Portable Document CBER, CDER, For CDER and CBER only: Portable Document Format (PDF) Specifications
Format CFSAN, CDRH,
(PDF) PDF Adobe 1.4-1.6 N/A CVM Ongoing
Documents For CDRH only: eCopy Program for Medical Device Submissions
CBER, CDER,
PDF PDF Adobe 1.7 N/A CDRH 11/20/2012
For full description of column headings, see Instr.& Column Descriptions tab
Date Support Date Requirement
Standards Supported Date Support Date Requirement
Data Exchange Exchange Begins Begins Statutory, Regulatory, or Guidance
Use Development Supported Version Implementation FDA Center(s) Ends Ends Information Sources
Standard Format (MM/DD/YYYY) (MM/DD/YYYY) Authority
Organization (SDO) Guide Version (MM/DD/YYYY) (MM/DD/YYYY)
[10] [11]
Sharing Structured
W3C - XML Technology
Information CBER, CDER,
XML W3C 1.0 CDRH Ongoing
Analysis program
ANSI
files CBER, CDER,
ASCII ANSI CDRH Ongoing
Clinical study 03/15/2019 [1] 12/17/2016 [1] 03/15/2019 [1] Standardized Study Data CDISC.org - SDTM
datasets SDTM XPT CDISC 1.2 3.1.2 CDER, CBER 10/30/2009 03/15/2020 [2] 12/17/2017 [2] 03/15/2020 [2]
Clinical study Version 3.1.2 03/15/2019 [1] 12/17/2016 [1] 03/15/2019 [1] Standardized Study Data CDISC.org- SDTM
datasets SDTM XPT CDISC 1.2 Amendment 1 CDER, CBER 08/07/2013 03/15/2020 [2] 12/17/2017 [2] 03/15/2020 [2]
Clinical study
12/17/2016 [1] Standardized Study Data CDISC.org - SDTM
datasets
SDTM XPT CDISC 1.3 3.1.3 CDER, CBER 12/01/2012 03/15/2021 12/17/2017 [2] 03/15/2021
Clinical study
03/15/2018 [1] Standardized Study Data CDISC.org- SDTM
datasets
SDTM XPT CDISC 1.4 3.2 CDER, CBER 08/17/2015 03/15/2019 [2]
Clinical study
Standardized Study Data CDISC.org- SDTM
datasets
SDTM XPT CDISC 1.7 3.3 CDER, CBER 03/15/2021 03/15/2023
Animal Rule study
3/15/2022 [1] Standardized Study Data CDISC.org- SDTM
datasets
SDTM XPT CDISC 1.8 SENDIG-AR v1.0 CDER 03/15/2020 3/15/2023 [2]
Clinical study
Analysis Data 03/15/2019 [1] 12/17/2016 [1] 03/15/2019 [1] Standardized Study Data CDISC.org - ADaM
datasets
Model (ADaM) XPT CDISC 2.1 1.0 CDER, CBER Ongoing 03/15/2020 [2] 12/17/2017 [2] 03/15/2020 [2]
Clinical study
03/15/2019 [1] Standardized Study Data CDISC.org - ADaM
datasets
ADaM XPT CDISC 2.1 1.1 CDER, CBER 03/15/2018 03/15/2020 [2]
Animal study
Standardized Study Data CDISC.org - SEND
datasets 03/15/2019 [1]
SEND XPT CDISC 1.5 3.1 CDER 08/21/2017 03/15/2020 [2]
Animal study
Standardized Study Data CDISC.org - SEND
datasets
SEND XPT CDISC 1.5 3.1 CBER 03/15/2021 03/15/2023
Nonclinical study
Standardized Study Data CDISC.org - SEND
datasets 03/15/2023 [1]
SEND XPT CDISC 1.6 SENDIG-DART v1.1 CDER 03/05/2021 03/15/2024 [2]
Study data
Standardized Study Data CDISC.org - Define-XML
definition 12/17/2016 [1]
Define XML CDISC 1.0 N/A CDER, CBER Ongoing 03/15/2018 12/17/2017 [2] 03/15/2018
Study data
Standardized Study Data CDISC.org - Define-XML
definition 12/17/2016 [1]
Define XML CDISC 2.0 N/A CDER, CBER 08/07/2013 12/17/2017 [2]
Study data
Standardized Study Data CDISC.org - Define-XML
definition
Define XML CDISC 2.1 N/A CDER, CBER 03/15/2021 03/15/2023
FDA Data Standards Catalog v7.3 (09-14-2021) - Supported and Required Standards
For full description of column headings, see Instr.& Column Descriptions tab
Date Support Date Requirement
Standards Supported Date Support Date Requirement
Data Exchange Exchange Begins Begins Statutory, Regulatory, or Guidance
Use Development Supported Version Implementation FDA Center(s) Ends Ends Information Sources
Standard Format (MM/DD/YYYY) (MM/DD/YYYY) Authority
Organization (SDO) Guide Version (MM/DD/YYYY) (MM/DD/YYYY)
[10] [11]
Structured Product
Structured Product Labeling (SPL) Implementation Guide
SPLIMAGE
with Validation
File Specification
Proceduresv3.02
(Section 3.2.12, 3.2.19, and Table 4)
Labeling
CDER, CBER,
SPL Image JPG, XML FDA and NLM 3.02 N/A CVM 03/21/2012 03/21/2012 [7]
International Institute of
High-througput HTS
Electrical and CDER, CBER,
Sequencing (HTS) BioCompute Bioinformatics Current Version N/A 03/15/2021 N/A https://standards.ieee.org/standard/
Electronics Engineers CFSAN
Data workflows
(IEEE)
Notes:
[1] For NDAs, ANDAs, and certain BLAs. See section II.A of the Providing Regulatory Submissions In Electronic Format — Standardized Study Data guidance document
[2] For certain INDs. See section II.A of the Providing Regulatory Submissions In Electronic Format - Standardized Study Data
[3] Providing Regulatory Submissions in Electronic Format - Content of Labeling
[4] The requirements of the electronic labeling rule can be found in § 314.50(l) for NDAs, § 314.94(d) for ANDAs, § 601.14(b) for BLAs, and § 314.81(b) for annual reports to marketing applications. The effective date of the rule was June 8, 2004.
[5] For NDAs, ANDAs, and BLAs. See section B of the Providing Regulatory Submissions in Electronic Format - Certain Human Pharmaceutical Product Applications and Related Submission Using the eCTD Specifications guidance document
[6] For Commercial INDs and Master Files. See section B of the Providing Regulatory Submissions in Electronic Format - Certain Human Pharmaceutical Product Applications and Related Submission Using the eCTD Specifications guidance document
[7] The pill image is optional, but it is highly recommended to address numerous potential patient safety issues. Also see Federal Register Volume 76, Number 99, and Federal Register Volume 79, Number 182 as background.
[8] " Ongoing"- Prior to the posting of a FDA Data Standards Catalog in 2011, FDA supported a number of data standards and there was no specific date when support began for some of these standards. As a result, the support status of “Ongoing” was entered for “Date Support Begins”.
[9] The simplified TS.xpt is a specific implementation of the CDISC SDTM standard being utilized by FDA (CDER and CBER) to establish the study start date or indicate that the study is exempted for evaluation by the Study Data Technical Rejection Criteria (TRC). For specifics on how to implement the simplified TS.xpt, please refer to the Study Data Technical Conformance Guide
[10] Please see the Study Data Technical Conformance Guide for clarification regarding when electronic standardized study data are required as part of a submission to address a public health emergency declared by the Secretary of Health and Human Services in accordance with section 319(a) of the Public Health Service Act (42 U.S.C. 247d(a)).
[11] Please see the Study Data Technical Conformance Guide for clarification regarding when electronic standardized study data are required for particular types of studies, such as pilot studies and failed studies submitted to ANDAs.
FDA Data Standards Catalog v7.3 (09-14-2021)
For full description of column headings, see Instr. & Column Descriptions tab
Date
Terminology Standards Date
Date Support Date Support Requirement
Terminology Development and/or Requirement Statutory, Regulatory, or
Use Version(s) FDA Center(s) Begins Ends Begins Examples of Use Information Sources
Standard Maintenance Ends Guidance Authority
(MM/DD/YYYY) (MM/DD/YYYY) (MM/DD/YYYY)
Organization (MM/DD/YYYY)
[10] [11]
Clinical Data
Interchange
General Clinical Standards CDISC/NCI Enterprise 2011-06-10 or 12/17/2016 [1]
CBER, CDER 06/13/2011 Use CDISC Submission values Standardized Study Data Index of CDISC SDTM Terminology Study Data Technical Conformance Guide
Data Consortium Vocabulary Services (EVS) later 12/17/2017 [2]
(CDISC)
Terminology
Medical Dictionary
Maintenance and Support
Adverse Events for Regulatory 03/15/2019 [1] 12/17/2016 [1] 03/15/2019 [1]
Services Organization 8 or earlier CBER, CDER Ongoing CDISC AE Domain Standardized Study Data MedDRA.org Study Data Technical Conformance Guide
Activities 03/15/2020 [2] 12/17/2017 [2] 03/15/2020 [2]
(MSSO)
(MedDRA)
Logical
Observation
03/15/2020 [1]
Laboratory Test Identifiers Names Regenstrief Institute Latest Version CBER, CDER 10/20/2017 Use in SDTM LBLOINC Standardized Study Data LOINC Study Data Technical Conformance Guide
03/15/2021 [2]
Name and Codes
(LOINC)
Department of Veterans
Affairs/Veterans Health
Use in SDTM and SEND TS
Administration designated MED-RT
domain for TSVAL where
federal collaborative that is
TSPARMCD=PCLAS and
named the "Structured
12/17/2016 [1] TSPARM = Pharmacologic Class.
Pharmacological Product Labeling
MED-RT Latest Version CBER, CDER Ongoing 12/17/2017 [2] Use FDA established Guidance for Industry: Labeling for Human Prescription Drug and Biological
Study
Products-Determining
Data Technical Conformance
EstablishedGuide
Pharmacologic Class for Use in the Highlights of Prescribing Information
Class Interagency Expert Panel"
05/06/2004 [3] Pharmacologic Class for all FDA
(SPLIEP). It includes
approved moieties (see
representation from FDA,
References). Use also in SDTM Pharmacologic Class
VA, NLM, and NCI. It is
CMCLAS.
published through NLM
and NCI EVS.
BGN
Dun and Bradstreet
FDA Structured Product Labeling Resources
HL7 International Downstream use in clinical
ISO descision support systems, third
Product Labeling Structured Product CDER, CBER,
NCI n/a April 2005 party reimbursement systems, and Providing Regulatory Submissions in Electronic Format - Content of Labeling
Submissions Labeling (SPL) CVM
NLM medical information management
Regenstrief Institute systems.
SNOMED International
USP
VA
FDA Data Standards Catalog v7.3 (09-14-2021)
For full description of column headings, see Instr. & Column Descriptions tab
BGN
Dun and Bradstreet Date
Terminology Standards Date
FDA Date Support Date Support Requirement
Terminology Development and/or Requirement Statutory, Regulatory, or
Use HL7 International Version(s) FDA Center(s) Begins Ends Begins Examples
Downstream useofinUse
clinical Information Sources
Standard Maintenance Ends Guidance Authority
ISO (MM/DD/YYYY) (MM/DD/YYYY) (MM/DD/YYYY) descision support systems, third
Product Labeling Structured Product Organization CDER, CBER, (MM/DD/YYYY)
NCI n/a [10] 2005
April [11] party reimbursement systems, and Providing Regulatory Submissions in Electronic Format - Content of Labeling
Submissions Labeling (SPL) CVM
NLM medical information management
Regenstrief Institute systems.
SNOMED International
USP SPL Terminology
VA
Geopolitical Entity
Country Codes Working
Countries (e.g.,
Geopolitical Group, National Center for Any database, report, or
United States) and United States Public Law 80-242 (1947) GENC Terminology
Entities, Names, Geospatial Intelligence submission that stores and/or
their Principal Current Version FDA Center(s) 12/17/2015 12/17/2020
and Codes Standards (NCGIS), displays Countries and their
Subdivisions (e.g.,
(GENC) National Geospatial- Principal Subdivisions
Maryland)
Intelligence Agency (NGA)
NSG Documents Registry
Notes:
[1] For NDAs, ANDAs, and certain BLAs. See section II.A of the Providing Regulatory Submissions In Electronic Format — Standardized Study Data guidance document
[2] For certain INDs. See section II.A of the Providing Regulatory Submissions In Electronic Format - Standardized Study Data
[3] White House Consolidated Health Informatics Initiative. See Federal Register Notices.
[4] The WHO Drug Dictionary is named WHODrug Global
[5] Earlier versions (e.g., B2 Format) will not be supported by Uppsala Monitoring Centre after March 2019
[6] GENC- For all new systems and major systems redesign
[7] GENC - For all legacy systems
[8] " Ongoing"- Prior to the posting of a FDA Data Standards Catalog in 2011, FDA supported a number of data standards and there was no specific date when support began for some of these standards. As a result, the support status of “Ongoing” was entered for “Date Support Begins”.
[9] The simplified TS.xpt is a specific implementation of the CDISC SDTM standard being utilized by FDA (CDER and CBER) to establish the study start date or indicate that the study is exempted for evaluation by the Study Data Technical Rejection Criteria (TRC). For specifics on how to implement the simplified TS.xpt, please refer to the Study Data Technical Conformance Guide
[10] Please see the Study Data Technical Conformance Guide for clarification regarding when electronic standardized study data are required as part of a submission to address a public health emergency declared by the Secretary of Health and Human Services in accordance with section 319(a) of the Public Health Service Act (42 U.S.C. 247d(a)).
[11] Please see the Study Data Technical Conformance Guide for clarification regarding when electronic standardized study data are required for particular types of studies, such as pilot studies and failed studies submitted to ANDAs.
Change History
Date Version
2011-06-13 1.0 Initial Release
2012-02-15 2.0 Added CDRH-supported data standards; added change history worksheet
Added support for SDTM v1.3/I.G. v3.1.3/define.xml 1.0; changed use of ASCII for the
2013-02-01 2.1
more generic "analysis program files"; Added support end date for SDTM IG 3.1.1
Added support for define.xml 2.0; added additional reference link for SNOMED CT and
2013-08-15 2.2 updated the "use" column; fixed links in reference column for Pharmacological class
terminology; updated link in reference column for Adverse Events Terminology.
Instructions:
· Edited text in the Instructions tab for the Date Support Ends item.
Data Exchange Standards:
· Added dates to the Date Requirement Begins column for appropriate data exchange
standards
· Edited Postmarketing Safety Reporting- Adverse Events for Animal Drugs (ICSR) to
correct Data Exchange Standard and SDO columns.
· Edits Postmarketing Safety Reporting - Adverse Events for Drugs and Biologics (ICSR) to
correct Data Exchange Standard and Supported Version columns.
2015-04-09 4.1
· Added new row for Postmarketing Safety Reporting- Adverse Events for Vaccines
· Added new row for Postmarketing Safety Reporting- Lot Distribution Reports
· Separated CDER and CBER PDF Data Exchange Standards rows from other Centers
· Corrected Data Exchange Standards, Standard for Exchange of Nonclinical Data (SEND)
Implementation Guide Version from "3.1.2" to "3.0".
· Added values to the Date Requirement Begins columns on the Data Exchange Standards
Terminology Standards:
· Added dates to the Date Requirement Begins column for appropriate terminologies
· Add 1 row: Terminology (Medication) Who Drug Dictionary
Terminology Standards:
2015-04-29 4.2
· Add 1 row: Terminology (Laboratory Test) LOINC
Data Exchange Standards:
2015-05-27 4.3 - Added dates to Date Requirement Begins column for Electronic Common Technical
Document (eCTD) standard
Change History
Date Version
Data Exchange Standards:
- Added new row for SDTM v1.4 & IG v3.2 support
2015-08-17 4.4
Terminology Standards:
-Added requirement date for LOINC
Terminology Standards:
- Updated FDA Centers That Use This Terminology column to reflect CBER
implementation
- Added row for CDISC Terminology for Non Clinical Data Terminology Type
CDISC
Terminology Standards:
- Updated Maintenance Organization for WHO Drug Dictionary
Terminology Standards:
- Updated LOINC Date Support Begins to 10/20/2017
2017-10-20 4.9
- Extended LOINC Date Requirement Begins for ANDA, NDA, certain BLAs & certain INDs
Terminology Standards:
- Added footnote 4 and 5
- Updated WHO Drug Dictionary Date Support Ends and Date Requirement Ends
2017-10-24 4.10 - Updated WHO Drug Dictionary version to Not Specified
- Added new row for WHODrug Global B3 Format Annual with the Date Support Begins
and Date Requirement Begins
- Added Footnote 4 & 5
Change History
Date Version
Intro & Definition of Terms:
- Renamed tab to Instr. and Column Descriptions
- Updated language in the instructions for use
- Updated the title of the Columns and Description sections
- Clarified the Description of each Catalog Term
Data
Exchange Standards: - Added
Statutory, Regulatory, or Guidance Authority column and links
- "Use" column is now the first column
- Updated the links within the Information Sources column -
Added new row for SPL image
- Added footnote #7
2018-04-20 5.0
Terminology Standards:
- Renamed Terminology Type to "Use"
- "Use" column is now the first column
- Renamed column FDA Centers That Use This Terminology to FDA Center(s)
- Added Statutory,
Regulatory, or Guidance Authority column and links
- Removed IHTSDO
- Added Technical Conformance Guide (TCG) to each cell that contained
Standarized Study Data under information sources column
- Added CFSAN as one of the centers that requires UNII
- Added new row for ICSR
- Added new row for SPL
- Removed original Information Source column and added a new Information Source
column to include TCG
Terminology Standards:
2018-08-02 5.1 - Name change from National Drug File- Reference Terminology to Medication Reference
Terminology (Med-RT) in March 2018
Terminology Standards:
- Updated MED-RT information sources
2018-12-19 5.2
- Updated all Study Data Technical Conformance Guide that has a new link
- Updated example of use for SNOMED CT
Terminology Standards:
2019-09-09 6.1
- UCUM terminology standard added to the catalog
Terminology Standards:
- Footnote 9 added